Showing results (1361-1370 of 1,512) with videos related to
Sort By:
Pageof 152
Kidney Research and Clinical Practice|November 16, 2021
Metabolic risks in living kidney donors in South KoreaEunjeong Kang, Jina Park, Hyo Jeong Kim, et al.The Lancet. Respiratory Medicine|December 19, 2022
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN studyBenjamin J Solomon, Todd M Bauer, Tony S K Mok, et al.BMC Cancer|November 3, 2007
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancerBhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, et al.The Oncologist|October 5, 2014
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study GroupTae Min Kim, Dong-Wan Kim, Yoon-Koo Kang, et al.Future Oncology (London, England)|October 3, 2024
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancerBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2024
Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN StudyBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.The Korean Journal of Internal Medicine|November 16, 2018
Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?Shin Hye Yoo, Chan-Young Ock, Bhumsuk Keam, et al.BMC Nephrology|July 22, 2015
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantationJin Ho Hwang, Jiwon Ryu, Jung Nam An, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancerYoungil Koh, Bogun Jang, Sae-Won Han, et al.Journal of Korean Medical Science|February 6, 2009
The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortalityHo Jun Chin, Hyun Jin Cho, Tae Woo Lee, et al.Pageof 152